Back
U.S. Bancorp Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
46
USB
U.S. Bancorp
Last Price:
47.20
Seasonality Move:
4.16%
Buy
82
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Sell
46
U.S. Bancorp (USB)
is a Sell
Is U.S. Bancorp a Buy, Sell or Hold?
- The current U.S. Bancorp [USB] share price is $47.84. The Score for USB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- USB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $319.58. The Score for MDGL is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
USB Stock Price Chart
What is U.S. Bancorp's stock price today?
-
The U.S. Bancorp share price today is $47.84
The current trend is moderately bearish and USB is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $319.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
USB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.82 | Buy |
Relative Strength Index (14 RSI): | 54.24 | Buy |
Chaikin Money Flow: | -5204743 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.97 - 48.51) | Buy |
Bollinger Bands (100): | (41.12 - 46.82) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.37 | Buy |
Relative Strength Index (14 RSI): | 85.5 | Buy |
Chaikin Money Flow: | 2945933 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (194.64 - 241.02) | Buy |
Bollinger Bands (100): | (221.59 - 279.03) | Buy |
USB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.3 | Sell |
20-day SMA: | 47.23 | Buy |
50-day SMA: | 46.08 | Buy |
200-day SMA: | 42.78 | Buy |
8-day EMA: | 48.14 | Sell |
20-day EMA: | 47.44 | Buy |
50-day EMA: | 46.08 | Buy |
200-day EMA: | 43.02 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 230.72 | Buy |
20-day SMA: | 219.8 | Buy |
50-day SMA: | 228.31 | Buy |
200-day SMA: | 241.11 | Buy |
8-day EMA: | 244.62 | Buy |
20-day EMA: | 228.06 | Buy |
50-day EMA: | 230.04 | Buy |
200-day EMA: | 234.49 | Buy |
U.S. Bancorp Earnings Growth & USB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.38 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
U.S. Bancorp Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |